PTK2 and osteosarcoma: The fact that FAK inhibitors reversed NGF-enhanced c-Src phosphorylation suggests that in human osteosarcoma, NGF activates the FAK and c-Src signaling pathways and in so doing promotes VCAM-1-regulated monocyte adhesion.